1. Home
  2. CCSI vs ALT Comparison

CCSI vs ALT Comparison

Compare CCSI & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCSI
  • ALT
  • Stock Information
  • Founded
  • CCSI 2021
  • ALT 1997
  • Country
  • CCSI United States
  • ALT United States
  • Employees
  • CCSI N/A
  • ALT N/A
  • Industry
  • CCSI Retail: Computer Software & Peripheral Equipment
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCSI Technology
  • ALT Health Care
  • Exchange
  • CCSI Nasdaq
  • ALT Nasdaq
  • Market Cap
  • CCSI 464.9M
  • ALT 457.0M
  • IPO Year
  • CCSI N/A
  • ALT N/A
  • Fundamental
  • Price
  • CCSI $25.67
  • ALT $7.61
  • Analyst Decision
  • CCSI Hold
  • ALT Buy
  • Analyst Count
  • CCSI 5
  • ALT 6
  • Target Price
  • CCSI $23.60
  • ALT $18.80
  • AVG Volume (30 Days)
  • CCSI 131.5K
  • ALT 1.9M
  • Earning Date
  • CCSI 11-07-2024
  • ALT 11-12-2024
  • Dividend Yield
  • CCSI N/A
  • ALT N/A
  • EPS Growth
  • CCSI 35.51
  • ALT N/A
  • EPS
  • CCSI 4.70
  • ALT N/A
  • Revenue
  • CCSI $353,962,000.00
  • ALT $409,000.00
  • Revenue This Year
  • CCSI N/A
  • ALT N/A
  • Revenue Next Year
  • CCSI N/A
  • ALT N/A
  • P/E Ratio
  • CCSI $5.55
  • ALT N/A
  • Revenue Growth
  • CCSI N/A
  • ALT N/A
  • 52 Week Low
  • CCSI $11.62
  • ALT $2.32
  • 52 Week High
  • CCSI $28.10
  • ALT $14.84
  • Technical
  • Relative Strength Index (RSI)
  • CCSI 72.26
  • ALT 62.72
  • Support Level
  • CCSI $21.61
  • ALT $6.45
  • Resistance Level
  • CCSI $27.23
  • ALT $8.05
  • Average True Range (ATR)
  • CCSI 0.95
  • ALT 0.41
  • MACD
  • CCSI 0.58
  • ALT 0.07
  • Stochastic Oscillator
  • CCSI 84.09
  • ALT 63.12

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: